Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Roshni Kalkur"'
Publikováno v:
Molecular pharmacology. 100(2)
The nontaxane microtubule inhibitor eribulin is an approved therapeutic for metastatic breast cancer and liposarcoma. Eribulin was previously tested in unselected patients with lung cancer and yielded a modest objective response rate of ∼5%–12%.
Publikováno v:
Obstetrics & Gynecology. 135:141S